Saralasin | |
---|---|
(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-(diaminomethylideneamino)-2-[[2-(methylamino)acetyl]amino]pentanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylbutanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]pyrrolidine-2-carbonyl]amino]propanoic acid |
|
Other names
Sar-Arg-Val-Tyr-Val-His-Pro-Ala |
|
Identifiers | |
CAS number | 34273-10-4 |
PubChem | 6324663 |
ChEMBL | CHEMBL938 |
Jmol-3D images | Image 1 |
|
|
Properties | |
Molecular formula | C42H65N13O10 |
Molar mass | 912.05 g/mol |
(verify) (what is: / ?) Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) |
|
Infobox references |
Saralasin is a competitive inhibitor of angiotensin II. It is an angiotensin II analogue, containing sarcosine-1 and alanine-8, hence the name (sarcosine, alanine, angiotensin).